Lamisil Once

Terbinafine, the active ingredient in Lamisil Once, is an allylamine presented as a topical formulation for skin application. It works by inhibiting fungal squalene epoxidase, thereby disrupting ergosterol synthesis and halting the growth of dermatophytes. The product is indicated for the treatment of superficial fungal infections of the skin and nails in both adults and children.

GNH USA supplies Lamisil Once as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured shipments that meet EU regulatory standards.

Terbinafine is an allylamine antifungal that targets dermatophyte infections of the skin.

Athlete's foot (tinea pedis): clears infection and relieves itching and scaling. Ringworm (tinea corporis): eliminates fungal growth and promotes lesion resolution. Jock itch (tinea cruris): reduces redness and clears the affected area. Nail fungus (tinea unguium) – superficial involvement: improves nail appearance and reduces fungal load.

Topical terbinafine may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Burning or stinging at the application site - Redness or erythema - Itching or pruritus

Serious or Rare Side Effects: - Severe allergic reaction such as angioedema or anaphylaxis - Contact dermatitis with blistering or swelling - Systemic hypersensitivity presenting as fever, malaise, or widespread rash

When using Lamisil Once, consider the following safety measures to minimize risk and ensure effective therapy.

Avoid use on broken or inflamed skin: apply only to intact epidermis. Do not cover treated area with occlusive dressings unless directed: may increase absorption. Limit treatment duration to the prescribed period: prolonged use can increase irritation. Discontinue if severe irritation or allergic reaction occurs: seek medical advice. Store at room temperature (below 25 °C): keep in original packaging, protect from moisture and direct sunlight.

Terbinafine may interact with other topical agents or systemic medications that affect liver enzymes or skin integrity.

Major Interactions (Avoid): - Concurrent use with other topical antifungals containing azoles: may increase local irritation. - Systemic terbinafine therapy: combined use can raise systemic exposure and risk of hepatotoxicity.

Moderate Interactions (Monitor Closely): - Topical corticosteroids applied to the same site: may mask signs of irritation. - Alcohol‑based skin products: may enhance absorption and cause burning.